Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
SIGA
AddedFeb 19, 2024
UpdatedJul 4, 2026
SIGA

SIGA

Public

SIGA Technologies: A US-based pharmaceutical firm specializing in oral antiviral drugs for smallpox treatment.

HQ
New York City, NY, US
Founded
1995
Overview
Compare
Fundraising
Employees
Website

Founded in the United States, SIGA Technologies is a commercial-stage pharmaceutical company dedicated to developing and providing antiviral drugs, with a core mission to combat infectious diseases. The company's primary product is an oral formulation designed to treat human smallpox disease caused by the variola virus. SIGA focuses on expanding its market reach and product pipeline to address unmet medical needs in antiviral treatments.

Notable figures affiliated with SIGA Technologies include a team of experienced scientists and business leaders who drive the company's innovation and growth. The company has established a rich history of successful partnerships that bolster its mission. Key achievements include the development and commercialization of its antiviral drug, which has had a significant impact on public health preparedness against smallpox.

SIGA - Similar Companies

Sigyn Therapeutics logo

Sigyn Therapeutics

Enanta Pharmaceuticals logo

Enanta Pharmaceuticals

enanta.com

Rigel Pharmaceuticals logo

Rigel Pharmaceuticals

rigel.com

Sequella logo

Sequella

Chimerix logo

Chimerix

Gilead Sciences logo

Gilead Sciences

gilead.com

Salix Pharmaceuticals logo

Salix Pharmaceuticals

salix.com

Soligenix logo

Soligenix

Savoy Pharmaceuticals logo

Savoy Pharmaceuticals

Emergent BioSolutions logo

Emergent BioSolutions

Atea Pharmaceuticals logo

Atea Pharmaceuticals

ateapharma.com

Assertio Holdings logo

Assertio Holdings

SIG logo

SIG

Solaris Pharma logo

Solaris Pharma

solaris-pharma.com

Globavir Biosciences logo

Globavir Biosciences

SIGA - Quick Facts

Who are SIGA's competitors?

Companies similar to SIGA include Sigyn Therapeutics, Enanta Pharmaceuticals, Rigel Pharmaceuticals and Sequella.

When was SIGA founded?

SIGA was founded in 1995.

Where is SIGA's headquarters located?

SIGA's headquarters is located in New York City, NY, US.

When was SIGA's last funding round?

SIGA's most recent funding round was for $23M (USD) in June 2020.

How much has SIGA raised to-date?

As of Jun 17, 2020, SIGA has raised a total of $110.6M (USD).

How many employees does SIGA have?

SIGA has 39 employees as of Feb 6, 2024.

SIGA - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Pharmaceuticals
Unique IDs
  • secCik: 0001010086
  • ticker: SIGA
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research